Viral hepatitis is a major public health threat and a leading cause of death worldwide.
Annual mortality from viral hepatitis is similar to that of other major infectious diseases such …

Of∼ 10.2 million people with chronic HCV infection in Europe, 6.7 million live in Eastern
Europe, 2.3 million in Western Europe and 1.2 million in Central Europe. HCV transmission …

Hepatitis B (HBV) is a major cause of global morbidity and mortality, and the leading cause
of liver cancer worldwide. Significant advances have recently been made toward the …

Objectives To assess progress in Australia toward the 2030 WHO hepatitis C elimination
targets two years after the introduction of highly effective direct‐acting antiviral (DAA) …

It is not often the world has the opportunity to turn a public health crisis into a good news
story. 1, 2 The development of oral, highly effective, pangenotypic direct-acting antivirals …

Background Timely diagnosis and treatment of hepatitis C virus (HCV) is critical to achieve
elimination goals. This study evaluated the cost-effectiveness of point-of-care testing …

Direct-acting antivirals (DAAs) have dramatically changed the landscape of hepatitis C
treatment and prevention. The World Health Organization has called for the elimination of …

Background Catalonia requires decentralized and simplified strategies for the diagnosis of
viremic HCV infection among people who inject drugs (PWID). We aimed to perform a direct …

Background & Aims High HCV treatment uptake among people at most risk of transmission
is essential to achieve elimination. We aimed to characterise subpopulations of people with …

The aim of this analysis was to evaluate perceived barriers related to HCV testing,
management and treatment among physicians practicing in clinics offering opioid agonist …